tradingkey.logo

Biocryst Announces Sale Of European Orladeyo(Berotralstat) Business To Neopharmed Gentili For Up To $264 Million

ReutersJun 27, 2025 11:14 AM

- BioCryst Pharmaceuticals Inc BCRX.O:

  • BIOCRYST ANNOUNCES SALE OF EUROPEAN ORLADEYO® (BEROTRALSTAT) BUSINESS TO NEOPHARMED GENTILI FOR UP TO $264 MILLION

  • BIOCRYST PHARMACEUTICALS INC - NEOPHARMED GENTILI TO PAY BIOCRYST $250 MILLION UPFRONT FOR ORLADEYO

  • BIOCRYST PHARMACEUTICALS INC - EXPECTS TO END 2027 WITH $700 MILLION IN CASH

  • BIOCRYST PHARMACEUTICALS INC - TO USE PROCEEDS TO RETIRE ALL REMAINING TERM DEBT

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI